GSK CEO Garnier Rebuts Schering Prediction On Flonase OTC Switch
This article was originally published in The Pink Sheet Daily
Executive Summary
It is "bullish to say that the FDA is going to approve a switch in 2004," Garnier says in response to a statement by Schering CEO Hassan.
You may also be interested in...
Ivax Confident On Flonase Generic In 2004, Despite Bioequivalence Petition
Chicago law firm submits petition asking FDA to enforce standards in 2003 draft guidance on nasal inhalers. Client is unidentified, but is not GlaxoSmithKline. Ivax continues to expect approval of ANDA for fluticasone nasal spray this year.
US Medicare Plans 'Can' Cover Wegovy, CMS Says, But Will They?
Medicare is making clear that Part D ‘can’ cover GLP-1 inhibitors that are approved for cardiovascular indications – but in language that seems to leave plans considerable discretion for now. The formulary review process for 2025 may be a more important milestone for changes.